ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 48 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $508,000 | -37.6% | 70,611 | -26.1% | 0.01% | -26.3% |
| Q2 2022 | $814,000 | -37.7% | 95,611 | -34.3% | 0.02% | -24.0% |
| Q1 2022 | $1,306,000 | -35.3% | 145,611 | 0.0% | 0.02% | -32.4% |
| Q4 2021 | $2,017,000 | +23.1% | 145,611 | -5.2% | 0.04% | +19.4% |
| Q3 2021 | $1,639,000 | +18.6% | 153,611 | 0.0% | 0.03% | +24.0% |
| Q2 2021 | $1,382,000 | +464.1% | 153,611 | +329.7% | 0.02% | +733.3% |
| Q1 2019 | $245,000 | +85.6% | 35,750 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $132,000 | -46.1% | 35,750 | -7.7% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | -16.4% | 38,750 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $293,000 | -5.5% | 38,750 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $310,000 | -28.6% | 38,750 | 0.0% | 0.00% | -40.0% |
| Q4 2017 | $434,000 | +99.1% | 38,750 | +106.7% | 0.01% | +150.0% |
| Q3 2017 | $218,000 | – | 18,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |